Calamos Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.33M | Sell |
37,720
-2,806
| -7% | -$776K | 0.03% | 452 |
|
|
2026
Q1 | $12M | Buy |
40,526
+2,106
| +5% | +$626K | 0.04% | 362 |
|
|
2025
Q4 | $10.5M | Sell |
38,420
-1,558
| -4% | -$423K | 0.04% | 382 |
|
|
2025
Q3 | $10.8M | Hold |
39,978
| – | – | 0.04% | 384 |
|
|
2025
Q2 | $11M | Hold |
39,978
| – | – | 0.04% | 384 |
|
|
2025
Q1 | $10.6M | Buy |
39,978
+495
| +1% | +$122K | 0.05% | 378 |
|
|
2024
Q4 | $9.17M | Hold |
39,483
| – | – | 0.04% | 417 |
|
|
2024
Q3 | $8.71M | Sell |
39,483
-969
| -2% | -$201K | 0.04% | 442 |
|
|
2024
Q2 | $7.95M | Sell |
40,452
-1,477
| -4% | -$305K | 0.04% | 452 |
|
|
2024
Q1 | $9.03M | Sell |
41,929
-1,055
| -2% | -$222K | 0.04% | 423 |
|
|
2023
Q4 | $9.05M | Sell |
42,984
-561
| -1% | -$120K | 0.04% | 417 |
|
|
2023
Q3 | $8.72M | Hold |
43,545
| – | – | 0.05% | 432 |
|
|
2023
Q2 | $8.07M | Hold |
43,545
| – | – | 0.04% | 484 |
|
|
2023
Q1 | $8.34M | Sell |
43,545
-5,444
| -11% | -$984K | 0.04% | 499 |
|
|
2022
Q4 | $8.24M | Sell |
48,989
-8,662
| -15% | -$1.51M | 0.04% | 533 |
|
|
2022
Q3 | $10.2M | Hold |
57,651
| – | – | 0.05% | 464 |
|
|
2022
Q2 | $11.8M | Buy |
57,651
+1,553
| +3% | +$329K | 0.05% | 440 |
|
|
2022
Q1 | $13.3M | Buy |
56,098
+7,477
| +15% | +$1.76M | 0.05% | 426 |
|
|
2021
Q4 | $11.1M | Buy |
48,621
+1,882
| +4% | +$414K | 0.04% | 456 |
|
|
2021
Q3 | $9.04M | Buy |
46,739
+4,124
| +10% | +$836K | 0.04% | 457 |
|
|
2021
Q2 | $9.06M | Buy |
42,615
+9,693
| +29% | +$2.05M | 0.04% | 426 |
|
|
2021
Q1 | $6.72M | Buy |
32,922
+1,017
| +3% | +$200K | 0.04% | 449 |
|
|
2020
Q4 | $5.81M | Sell |
31,905
-1,425
| -4% | -$242K | 0.03% | 466 |
|
|
2020
Q3 | $5.58M | Sell |
33,330
-2,921
| -8% | -$492K | 0.04% | 436 |
|
|
2020
Q2 | $5.89M | Sell |
36,251
-2,316
| -6% | -$415K | 0.04% | 411 |
|
|
2020
Q1 | $6.67M | Sell |
38,567
-3,253
| -8% | -$647K | 0.05% | 343 |
|
|
2019
Q4 | $8.39M | Sell |
41,820
-651
| -2% | -$134K | 0.04% | 396 |
|
|
2019
Q3 | $8.98M | Buy |
42,471
+3,718
| +10% | +$777K | 0.05% | 369 |
|
|
2019
Q2 | $7.52M | Buy |
38,753
+1,929
| +5% | +$356K | 0.04% | 413 |
|
|
2019
Q1 | $6.06M | Buy |
36,824
+368
| +1% | +$65.1K | 0.04% | 417 |
|
|
2018
Q4 | $6.86M | Buy |
36,456
+5,458
| +18% | +$1.01M | 0.05% | 376 |
|
|
2018
Q3 | $5.28M | Buy |
+30,998
| New | +$5.22M | 0.03% | 450 |
|
|
2018
Q2 | – | Sell |
-1,430
| Closed | -$232K | – | 605 |
|
|
2018
Q1 | $232K | Hold |
1,430
| – | – | ﹤0.01% | 585 |
|
|
2017
Q4 | $209K | Buy |
+1,430
| New | +$204K | ﹤0.01% | 587 |
|
Other funds holding CME
AI
PAM
Calamos Advisors's CME Position: Q2 2026 in Review
Calamos Advisors reduced its CME Group (CME) stake by 6.9% in Q2 2026, selling an estimated $776K and leaving 37,720 shares worth $8.33M. The position accounts for 0.03% of the portfolio, ranked #452.
Calamos Advisors first reported a position in CME in Q4 2017 and has held it in 34 quarters since. The position peaked at $13.3M in Q1 2022. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Calamos Advisors held 37,720 shares of CME Group worth $8.33M as of Q2 2026.
- Calamos Advisors sold 2,806 CME Group shares in Q2 2026, an estimated $776K.
- CME Group made up 0.03% of Calamos Advisors's portfolio in Q2 2026, its #452 holding.
- Calamos Advisors first reported a position in CME Group in Q4 2017 and has held it in 34 quarters since.
- Calamos Advisors's CME Group position peaked at $13.3M in Q1 2022.
- 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.